Bookmark Article
Sibusiso, a 39-year-old HIV patient in Eswatini, faced uncertainty as the Trump administration paused PEPFAR, a vital AIDS relief program in Africa. The abrupt halt caused clinic closures, medication shortages, and fears of a return to the HIV epidemic’s darkest days. With staff shortages and treatment delays, lives were at risk as patients struggled to access essential medications and care.
Full Article